193 related articles for article (PubMed ID: 35628582)
1. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)-A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis.
Koszalka P; Kutryb-Zajac B; Mierzejewska P; Tomczyk M; Wietrzyk J; Serafin PK; Smolenski RT; Slominska EM
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628582
[TBL] [Abstract][Full Text] [Related]
2. An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite.
Mierzejewska P; Kunc M; Zabielska-Kaczorowska MA; Kutryb-Zajac B; Pelikant-Malecka I; Braczko A; Jablonska P; Romaszko P; Koszalka P; Szade J; Smolenski RT; Slominska EM
Exp Mol Med; 2021 Sep; 53(9):1402-1412. PubMed ID: 34580423
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 4-pyridone-3-carboxamide-1β-d-ribonucleoside (4PYR) in primary murine brain microvascular endothelial cells (mBMECs).
Pelikant-Małecka I; Smoleński RT; Słomińska EM
Nucleosides Nucleotides Nucleic Acids; 2018; 37(11):639-644. PubMed ID: 30663501
[TBL] [Abstract][Full Text] [Related]
4. 4-Pyridone-3-carboxamide-1β-D-ribonucleoside metabolism in endothelial cells and its impact on cellular energetic balance.
Pelikant-Małecka I; Sielicka A; Kaniewska E; Smoleński RT; Słomińska EM
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):338-41. PubMed ID: 24940690
[TBL] [Abstract][Full Text] [Related]
5. Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
Jedrzejewska A; Jablonska P; Gawlik-Jakubczak T; Czajkowski M; Maszka P; Mierzejewska P; Smolenski RT; Slominska EM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397036
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate and its nucleoside precursor in the erythrocytes.
Slominska EM; Orlewska C; Yuen A; Osman L; Romaszko P; Sokolowska E; Foks H; Simmonds HA; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):830-4. PubMed ID: 18600548
[TBL] [Abstract][Full Text] [Related]
7. In vitro and cellular effects of 4-pyridone-3-carboxamide riboside on enzymes of nucleotide metabolism.
Slominska EM; Borkowski T; Rybakowska I; Abramowicz-Glinka M; Orlewska C; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):353-7. PubMed ID: 24940693
[TBL] [Abstract][Full Text] [Related]
8. Influence of 4-pyridone-3-carboxamide-1Β-D-ribonucleoside (4PYR) on activities of extracellular enzymes in endothelial human cells.
Pelikant-Małecka I; Sielicka A; Kaniewska E; Smoleński RT; Słomińska EM
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):732-736. PubMed ID: 27906624
[TBL] [Abstract][Full Text] [Related]
9. Metabolic pathway of 4-pyridone-3-carboxamide-1β-d-ribonucleoside and its effects on cellular energetics.
Pelikant-Malecka I; Kaniewska-Bednarczuk E; Szrok S; Sielicka A; Sledzinski M; Orlewska C; Smolenski RT; Slominska EM
Int J Biochem Cell Biol; 2017 Jul; 88():31-43. PubMed ID: 28323211
[TBL] [Abstract][Full Text] [Related]
10. Effects of 4-Pyridone-3-carboxamide-1β-D-ribonucleoside on adenine nucleotide catabolism in the aortic wall; Implications for atherosclerosis in ApoE-/-LDLR-/- mice.
Zabielska M; Kutryb-Zajac B; Żukowska P; Slominska E; Smoleński R
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):720-725. PubMed ID: 27906619
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma concentration of 4-pyridone-3-carboxamide-1-ß-D-ribonucleoside (4PYR) in lung cancer. Preliminary studies.
Jablonska P; Mierzejewska P; Kutryb-Zajac B; Rzyman W; Dziadziuszko R; Polanska J; Sitkiewicz M; Smolenski RT; Slominska EM
Nucleosides Nucleotides Nucleic Acids; 2019; 38(10):781-787. PubMed ID: 30990116
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 4-pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) in rodent tissues and in vivo.
Romaszko P; Slominska EM; Orlewska C; Lipinski M; Smolenski RT
Mol Cell Biochem; 2011 May; 351(1-2):143-8. PubMed ID: 21312056
[TBL] [Abstract][Full Text] [Related]
13. A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate.
Slominska EM; Carrey EA; Foks H; Orlewska C; Wieczerzak E; Sowinski P; Yacoub MH; Marinaki AM; Simmonds HA; Smolenski RT
J Biol Chem; 2006 Oct; 281(43):32057-64. PubMed ID: 16920716
[TBL] [Abstract][Full Text] [Related]
14. Effect of 4-pyridone-3-carboxamide ribonucleoside (4PYR)-potential cardiovascular toxin in perfused rat heart.
Romaszko P; Slominska EM; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):333-7. PubMed ID: 24940689
[TBL] [Abstract][Full Text] [Related]
15. Endothelial toxicity of unusual nucleotide metabolites.
Pelikant-Malecka I; Sielicka A; Kaniewska E; Smolenski RT; Slominska EM
Pharmacol Rep; 2015 Aug; 67(4):818-22. PubMed ID: 26321286
[TBL] [Abstract][Full Text] [Related]
16. Distribution of purine nucleotides in uremic fluids and tissues.
Rutkowski B; Rutkowski P; Słomińska E; Swierczyński J
J Ren Nutr; 2010 Sep; 20(5 Suppl):S7-10. PubMed ID: 20797575
[TBL] [Abstract][Full Text] [Related]
17. Cellular toxicity of nicotinamide metabolites.
Rutkowski B; Rutkowski P; Słomińska E; Smolenski RT; Swierczyński J
J Ren Nutr; 2012 Jan; 22(1):95-7. PubMed ID: 22200423
[TBL] [Abstract][Full Text] [Related]
18. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
19. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Biochem Pharmacol; 1995 Jan; 49(1):49-56. PubMed ID: 7840782
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
Wang D; Xiao F; Feng Z; Li M; Kong L; Huang L; Wei Y; Li H; Liu F; Zhang H; Zhang W
Breast Cancer Res; 2020 Sep; 22(1):103. PubMed ID: 32993785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
